3 results
To demonstrate that treatment with drotrecogin alfa (activated) 24 mcg/kg/h administered as an intravenous infusion for 96 hours reduces 28 day all-cause mortality in adult patients with septic shock compared with placebo.
Primary objective: The primary objective of the study is to evaluate the dose-response of tofacitinib in inducing clinical remission in subjects with moderate to severe Crohn*s disease and to select effective doses. Secondary objectives: -To…
The purpose of the study is to validate the measurements of an activity and heart rate band. The primary objective of this study is to determine the measurement accuracy of the activity and heart rate band with regards to the measurement of energy…